Analysis of PEGylated Antibody Fragments using SEC-MALS

contributed by Tosoh | 08/23/2024

The covalent modification of proteins by conjugating polyethylene glycol (PEG) is an advanced tool to improve the pharmacokinetic behavior of small biotherapeutic drugs such as antibody fragments (e.g. Fabs or scFvs) and peptides. PEGylation is mainly used to improve drug solubility, increase serum half-life, reduce sensitivity to proteolysis, and reduce renal uptake, by masking the physical and chemical characteristics of the biotherapeutics (e.g. its conformation and hydrophobicity) resulting in reduced immunogenicity and new prospects of drug delivery[1].

One major challenge is the complete characterization of PEGylated protein samples. Since the PEGylation reaction is unspecific, mono-PEGylated as well as poly-PEGylated proteins may be present. Furthermore, by evaluating the amount of PEGylated protein, free protein, and free PEG, PEGylation efficiency can be determined, which enables optimization of the PEGylation reaction conditions.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.